A carregar...
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
BACKGROUND: Because the general population is largely naive to H5N1 influenza, antibodies generated to H5 allow analysis of novel influenza vaccines independent of background immunity from previous infection. We assessed the safety and immunogenicity of DNA encoding H5 as a priming vaccine to improv...
Na minha lista:
| Publicado no: | Lancet Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier Ltd.
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7185472/ https://ncbi.nlm.nih.gov/pubmed/21975270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(11)70240-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|